-
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of "Moderate Buy" from Brokerages
ソース: Buzz FX / 04 12 2024 03:36:12 America/New_York
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat December 4, 2024 Share Link copied to clipboard. Shares of BioCryst Pharmaceuticals, Inc.
Read more...